108 related articles for article (PubMed ID: 10212277)
1. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a).
Wang J; White AL
J Biol Chem; 1999 Apr; 274(18):12883-9. PubMed ID: 10212277
[TBL] [Abstract][Full Text] [Related]
2. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum.
White AL; Guerra B; Lanford RE
J Biol Chem; 1997 Feb; 272(8):5048-55. PubMed ID: 9030568
[TBL] [Abstract][Full Text] [Related]
3. Role of calnexin, calreticulin, and endoplasmic reticulum mannosidase I in apolipoprotein(a) intracellular targeting.
Wang J; White AL
Biochemistry; 2000 Aug; 39(30):8993-9000. PubMed ID: 10913312
[TBL] [Abstract][Full Text] [Related]
4. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
White AL; Guerra B; Wang J; Lanford RE
J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
[TBL] [Abstract][Full Text] [Related]
5. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
6. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
Klezovitch O; Edelstein C; Scanu AM
J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
[TBL] [Abstract][Full Text] [Related]
8. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.
Bonen DK; Nassir F; Hausman AM; Davidson NO
J Lipid Res; 1998 Aug; 39(8):1629-40. PubMed ID: 9717723
[TBL] [Abstract][Full Text] [Related]
10. Biogenesis of Lp(a) in transgenic mouse hepatocytes.
White AL
Clin Genet; 1997 Nov; 52(5):326-37. PubMed ID: 9520123
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon.
White AL; Hixson JE; Rainwater DL; Lanford RE
J Biol Chem; 1994 Mar; 269(12):9060-6. PubMed ID: 8132643
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation.
Nassir F; Xie Y; Davidson NO
J Lipid Res; 2003 Apr; 44(4):816-27. PubMed ID: 12562843
[TBL] [Abstract][Full Text] [Related]
13. A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation.
Becker L; Webb BA; Chitayat S; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Apr; 278(16):14074-81. PubMed ID: 12566443
[TBL] [Abstract][Full Text] [Related]
14. The binding of animal low-density lipoproteins to human apolipoprotein(a).
Trieu VN; McConathy WJ
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
Hermann A; Laws WR; Harpel PC
Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
[TBL] [Abstract][Full Text] [Related]
17. Transgenic rabbits expressing human apolipoprotein (a).
Fan J; Watanabe T
J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
[TBL] [Abstract][Full Text] [Related]
18. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10.
Rahman MN; Becker L; Petrounevitch V; Hill BC; Jia Z; Koschinsky ML
Biochemistry; 2002 Jan; 41(4):1149-55. PubMed ID: 11802713
[TBL] [Abstract][Full Text] [Related]
19. Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures.
Wang J; Boedeker J; Hobbs HH; White AL
J Lipid Res; 2001 Jan; 42(1):60-9. PubMed ID: 11160366
[TBL] [Abstract][Full Text] [Related]
20. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
